150 related articles for article (PubMed ID: 24870766)
21. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
[TBL] [Abstract][Full Text] [Related]
22. Expression and clinical significance of retinoid X receptor α in esophageal carcinoma.
Ren HY; Guo YH; Yang LM; Dai TJ; Lin MZ; Yu L; Zhu QG; Meng JR
Ann Diagn Pathol; 2018 Jun; 34():110-115. PubMed ID: 29661715
[TBL] [Abstract][Full Text] [Related]
23. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
24. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma.
Wei SH; Lin F; Wang X; Gao P; Zhang HZ
Acta Histochem; 2008; 110(1):59-65. PubMed ID: 18054374
[TBL] [Abstract][Full Text] [Related]
26. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
[TBL] [Abstract][Full Text] [Related]
27. STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells.
Akhtar J; Wang Z; Yu C; Li CS; Shi YL; Liu HJ
BMC Cancer; 2014 Jan; 14():28. PubMed ID: 24433541
[TBL] [Abstract][Full Text] [Related]
28. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer.
Ke B; Wu LL; Liu N; Zhang RP; Wang CL; Liang H
Tumour Biol; 2013 Oct; 34(5):3137-45. PubMed ID: 23760979
[TBL] [Abstract][Full Text] [Related]
31. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
32. Correlation between Vascular Endothelial Growth Factor C Expressior and Lymph Node Micrometastasis and Prognosis in Patients with pNO Esophageal Squamous Cell Carcinomas.
Sun ZG; Liu XY; Zhang M; Wang Z
Hepatogastroenterology; 2014 May; 61(131):671-7. PubMed ID: 26176055
[TBL] [Abstract][Full Text] [Related]
33. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.
Zhang SS; Xie X; Wen J; Luo KJ; Liu QW; Yang H; Hu Y; Fu JH
Diagn Pathol; 2016 Jan; 11():14. PubMed ID: 26818094
[TBL] [Abstract][Full Text] [Related]
34. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
Rong B; Nan Y; Liu H; Gao W
Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
[TBL] [Abstract][Full Text] [Related]
35. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
36. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
37. Rac GTPase-Activating Protein 1 (RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma.
Yin C; Toiyama Y; Okugawa Y; Shigemori T; Yamamoto A; Ide S; Kitajima T; Fujikawa H; Yasuda H; Okita Y; Hiro J; Yoshiyama S; Ohi M; Araki T; Yao L; Kusunoki M
Oncology; 2019; 97(3):155-163. PubMed ID: 31216559
[TBL] [Abstract][Full Text] [Related]
38. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
39. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
40. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]